Biotech · Private company
Adicet Therapeutics
Track this companyFree. Adds Adicet Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- ADI-212Phase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Prostate Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- ADI-001Phase 1 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- ADI-001Phase 1 · Lymphoma, FollicularClinicalTrials.gov · fetched Nov 12, 2026
- ADI-270Phase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Lymphoma, FollicularClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Lymphoma, FollicularClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Phase 1/2 Trial of ADI-212 in mCRPCPHASE1_PHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07793435 · fetched Nov 12, 2026
- A Phase 1 Trial of ADI-270 in ccRCCPHASE1 · TERMINATED · started Dec 12, 2024ClinicalTrials.gov NCT06480565 · fetched Nov 12, 2026
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune DiseasePHASE1 · ENROLLING_BY_INVITATION · started Nov 10, 2024ClinicalTrials.gov NCT06375993 · fetched Nov 12, 2026
- Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T CellsACTIVE_NOT_RECRUITING · started Feb 14, 2022ClinicalTrials.gov NCT04911478 · fetched Nov 12, 2026
- A Phase 1 Study of ADI-001 in B Cell MalignanciesPHASE1 · TERMINATED · started Mar 4, 2021ClinicalTrials.gov NCT04735471 · fetched Nov 12, 2026